Blood derivatives constitute a unique and separate group of speciality pharmaceutical products. Blood derivatives are defined as pharmaceutical products whose active ingredient is obtained from the plasma of healthy human donors through a process of separation (fractionation) and controlled purification.
The Banc de Sang i Teixits (Blood and Tissue Bank, BST) has signed a contract with the pharmaceutical industry to handle the fractionation of surplus donor plasma. Under the terms of this contract, the BST delivers its surplus plasma, and in exchange the industry supplies blood derivative drugs which we distribute to hospitals.
The products that the BST obtains from its fractionated plasma are:
High-purity human immunoglobulin
Compound of human coagulation factor VIII and Von Willebrand factor
Coagulation factor IX
Alpha-1-antitrypsin (AAT) concentrate with a high specific activity